COVID-19 vaccine hesitancy in Iranian patients with multiple sclerosis.

ABSTRACT:

Background

World Health Organization (WHO) mentioned COVID-19 vaccination as the safest way to eradicate this pandemic. In the meantime, vaccine hesitancy (a delay in accepting or rejecting the vaccine despite the availability of vaccination services) is a barrier. Hence, we studied this obstacle in the Iranian multiple sclerosis (MS) population.

Objective

MS patients eligible for vaccination were asked to complete a google form survey. Demographic information, MS disease-related factors, flu vaccination history, COVID-19 vaccination history, cause of vaccination refusal, past history of COVID-19 infection, and their compliance with public health guidelines after vaccination were recorded.

Results

1479 patients participated in this study. 6.9% of participants have not

SUBMITTER: Abbasi N 

PROVIDER: S-EPMC8896865 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature